Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

Conditions:   BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast CancerInterventions:   Dietary Supplement: soy isoflavones;   Other: placebo;   Other: questionnaire administration;   Procedure: magnetic resonance imaging;   Procedure: biopsy;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: mammographySponsors:   University of Southern California;   National Cancer Institute (NCI);   California Breast Cancer Research ProgramActive, not recruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials